Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII)

Piero Micossi, Emanuele Bosi, Marco Cristallo, Lucilla Domenica Monti, Maria Cristina Librenti, Giovanna Petrella, Gabriella Galimberti, Donatella Spotti, Gino Giudici, Carlo Vergani, Valerio Di Carlo, Guido Pozza

Research output: Contribution to journalArticle


Six unstable C-peptide negative type I diabetic patients who had been previously treated with continuous subcutaneous insulin infusion (CSII) for at least one year without achieving satisfactory metabolic control, were admitted to this study and switched to continuous intraperitoneal insulin infusion (CIPII). The results obtained with the two treatments have been compared from the metabolic and clinical points of view. CIPII produced a decrease in HbA1c (p2 fraction (p

Original languageEnglish
Pages (from-to)155-164
Number of pages10
JournalActa Diabetologica Latina
Issue number2
Publication statusPublished - Jun 1986



  • Implantable devices
  • Intraperitoneal insulin
  • Lipid metabolism
  • Metabolic control
  • Unstable diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this